Skip to main content
Erschienen in: Reactions Weekly 1/2022

01.07.2022 | Case report

Metoclopramide/olanzapine/quetiapine

Extrapyramidal symptoms and drug-drug pharmacokinetic interaction: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
  • * Drug interaction
Literatur
Zurück zum Zitat Sakamoto S, et al. Prolonged extrapyramidal symptoms induced by long-term, intermittent administration of low-dose olanzapine along with metoclopramide for emesis: A case report. Neuropsychopharmacology Reports : 1-4, 2022. Available from: URL: http://doi.org/10.1002/npr2.12277 Sakamoto S, et al. Prolonged extrapyramidal symptoms induced by long-term, intermittent administration of low-dose olanzapine along with metoclopramide for emesis: A case report. Neuropsychopharmacology Reports : 1-4, 2022. Available from: URL: http://​doi.​org/​10.​1002/​npr2.​12277
Metadaten
Titel
Metoclopramide/olanzapine/quetiapine
Extrapyramidal symptoms and drug-drug pharmacokinetic interaction: case report
Publikationsdatum
01.07.2022
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2022
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-022-19304-6

Weitere Artikel der Ausgabe 1/2022

Reactions Weekly 1/2022 Zur Ausgabe

Case report

Olanzapine

Case report

Azd-1222

Case report

Prednisolone